Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage
机构:[1]Department of Neurobiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China,[2]Bioinformatics Center, School of Biomedical Engineering, Capital Medical University, Beijing, China,[3]Department of Neurobiology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China,老年医学科首都医科大学宣武医院[4]Department of Statistics, Purdue University, West Lafayette, Indiana, United States of America,[5]Department of Neurology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China,神经内科老年医学科首都医科大学宣武医院[6]Key Laboratory on Neurodegenerative Disease of Ministry of Education and Key Laboratory on Parkinson’s Disease of Beijing, Beijing, China,[7]Department of Neurology, The Affiliated Sanming First Hospital of Fujian Medical University, Sanming, Fujian, China,[8]Parkinson Disease Center of Beijing Institute for Brain Disorders, Capital Medical University, Beijing, China,[9]Alzheimer Disease Center of Beijing Institute for Brain Disorders, Capital Medical University, Beijing, China
Many genetic variants have been linked to familial or sporadic Parkinson's disease (PD), among which those identified in PARK16, BST1, SNCA, LRRK2, GBA and MAPT genes have been demonstrated to be the most common risk factors worldwide. Moreover, complex gene-gene and gene-environment interactions have been highlighted in PD pathogenesis. Compared to studies focusing on the predisposing effects of genes, there is a relative lack of research investigating how these genes and their interactions influence the clinical profiles of PD. In a cohort consisting of 2,011 Chinese Han PD patients, we selected 9 representative variants from the 6 above-mentioned common PD genes to analyze their main and epistatic effects on the Unified Parkinson's Disease Rating Scale (UPDRS) and the Hoehn and Yahr (H-Y) stage of PD. With multiple linear regression models adjusting for medication status, disease duration, gender and age at onset, none of the variants displayed significant main effects on UPDRS or the H-Y scores. However, for gene-gene interaction analyses, 7 out of 37 pairs of variants showed significant or marginally significant associations with these scores. Among these, the GBA rs421016 (L444P)xLRRK2 rs33949390 (R1628P) interaction was consistently significant in relation to UPDRS III and UPDRS total (I+II+III), even after controlling for the family-wise error rate using False Discovery Rate (FDR-corrected p values are 0.0481 and 0.0070, respectively). Although the effects of the remaining pairs of variants did not survive the FDR correction, they showed marginally significant associations with either UPDRS or the H-Y stage (raw p<0.05). Our results highlight the importance of epistatic effects of multiple genes on the determination of PD clinical profiles and may have implications for molecular classification and personalized intervention of the disease.
基金:
the National Basic Research Program of China (2014CB744600, 2011CB504101),
the Ministry of Science and Technology of China (2012AA02A514),
Beijing Municipal Commission of Education (KM201410025013)
Beijing Institute for Brain Disorders(BIBDPXM2014_014226_000016).
第一作者机构:[1]Department of Neurobiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China,[2]Bioinformatics Center, School of Biomedical Engineering, Capital Medical University, Beijing, China,
共同第一作者:
通讯作者:
通讯机构:[1]Department of Neurobiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China,[2]Bioinformatics Center, School of Biomedical Engineering, Capital Medical University, Beijing, China,[3]Department of Neurobiology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China,[4]Department of Statistics, Purdue University, West Lafayette, Indiana, United States of America,[5]Department of Neurology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China,[6]Key Laboratory on Neurodegenerative Disease of Ministry of Education and Key Laboratory on Parkinson’s Disease of Beijing, Beijing, China,[8]Parkinson Disease Center of Beijing Institute for Brain Disorders, Capital Medical University, Beijing, China,[9]Alzheimer Disease Center of Beijing Institute for Brain Disorders, Capital Medical University, Beijing, China
推荐引用方式(GB/T 7714):
Chen Shi,Zheng Zheng,Qi Wang,et al.Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage[J].PLOS ONE.2016,11(6):e0155758.doi:10.1371/journal.pone.0155758.
APA:
Chen Shi,Zheng Zheng,Qi Wang,Chaodong Wang,Dabao Zhang...&Xiaomin Wang.(2016).Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage.PLOS ONE,11,(6)
MLA:
Chen Shi,et al."Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage".PLOS ONE 11..6(2016):e0155758